Volpara Health Technologies (ASX:VHT) reports excellent results in 2nd round in breast cancer screening

Company News

by Melissa Darmawan

Health software company Volpara Health Technologies (ASX:VHT) reports their trial in breast cancer screening had excellent results in the second-round.

The study used Volpara®Density™ software to assess breast density. The results showed a significant reduction in interval cancers in those women being selected for breast MRI. False-positive rate significantly reduced relative to first results two years ago.

Shares in Volpara Health Technologies (ASX:VHT) are trading 2.3 per cent higher at $1.32.

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.